Revolutionizing Learning and Medicine: Huawei's Bold New InitiativeHuawei's 2025 Global Education and Healthcare Partner Convention attracted over 300 guests from 40 countries to discuss innovations.
Huawei Unveils Ambitious Plan to Transform Education and Healthcare GloballyHuawei's 2025 Global Education and Healthcare Partner Convention gathered over 300 guests from 40 countries to discuss innovations.
Revolutionizing Weight Loss: AI-Driven Drug Discovery Takes Center StageDivamics showcases its AI-driven platform's impact on advancing therapeutics for metabolic diseases at a conference in Suzhou, China.
Celltrion Launches Affordable Biosimilars in the U.S. Market: A Game Changer for Patients!Celltrion launches denosumab biosimilars Stoboclo and Osenvelt in the US market, tapping into a $6.5 billion opportunity.
Breaking the Stigma: Why Obesity is a Chronic DiseaseThe campaign focuses on raising awareness of obesity as a chronic disease and providing management solutions for Thais and healthcare providers.
Investment Growth in 2024: Goldman Sachs Highlights Private Equity, AI, Software, and HealthcareGoldman Sachs Asset Management predicts 2024 will see private equity growth, private credit focus, and disruptive tech rise.
Revolutionizing Learning and Medicine: Huawei's Bold New Initiative Huawei's 2025 Global Education and Healthcare Partner Convention attracted over 300 guests from 40 countries to discuss innovations.
Huawei Unveils Ambitious Plan to Transform Education and Healthcare Globally Huawei's 2025 Global Education and Healthcare Partner Convention gathered over 300 guests from 40 countries to discuss innovations.
Revolutionizing Weight Loss: AI-Driven Drug Discovery Takes Center Stage Divamics showcases its AI-driven platform's impact on advancing therapeutics for metabolic diseases at a conference in Suzhou, China.
Celltrion Launches Affordable Biosimilars in the U.S. Market: A Game Changer for Patients! Celltrion launches denosumab biosimilars Stoboclo and Osenvelt in the US market, tapping into a $6.5 billion opportunity.
Breaking the Stigma: Why Obesity is a Chronic Disease The campaign focuses on raising awareness of obesity as a chronic disease and providing management solutions for Thais and healthcare providers.
Investment Growth in 2024: Goldman Sachs Highlights Private Equity, AI, Software, and Healthcare Goldman Sachs Asset Management predicts 2024 will see private equity growth, private credit focus, and disruptive tech rise.
Hot Topics